Continuing cancer treatment in a “COVID HOTSPOT” in India: Are we overestimating the risks?

Parasnis, Amit; Kelkar, Dhananjay; Khaladkar, Bhagyashree; Kurlekar, Utkrant; Deshmukh, Chetan; Pingle, Sonali; Hingmire, Sachin; Kulkarni, Padmaj; Shende, Shailesh; Phadke, Girish K.; Sambhus, Mahesh; Melinkeri, Sameer; Kanvinde, Shailesh

doi:10.4103/ijmpo.ijmpo_327_20

Cited by 2 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Due to the unique characteristics of the disease, cancer patients still need to continue taking medication after discharge, so extended care is needed to ensure standardized management of the patients. [12][13][14] Researchers such as Tan A.C. have found that some cancer patients had poor adherence to medical advice outside of hospital, and there was a high demand for medication guidance and follow-up outside of hospital. [15,16] Continuing care is an extended form of hospital care and a trend in the current medical care model.…”

Section: Discussionmentioning

confidence: 99%

Life quality improvement of patients with non-small cell lung cancer undergoing targeted therapy: A case study of continuous care

Min,

Zhu,

et al. 2023

Medicine

View full text Add to dashboard Cite

To investigate the improvement effect of targeted therapy on non-small cell carcinoma patients life quality after the continuous nursing intervention. 104 non-small cell lung cancer patients in our hospital from July 2017 to November 2019 were allocated evenly and randomly into the control group (C) and the study group (S). By using clinical baseline data, quality of life questionnaire core 30 for cancer patients, evaluation of patient compliance behavior, the MOS item short-form health survey (SF-36), self rating depression scale (SDS), self rating anxiety scale (SAS), Overall Survival (OS) progression-free survival and adverse reaction symptoms were evaluated for the life quality of patients. There was comparability between the 2 sets of basic data. There was no significant difference in quality of life questionnaire core 30, SF-36, SAS, or SDS scores before treatment. After 3 months, there was a significant difference in the scores of various scales before treatment. At the same time, there was significant statistical significance before and after treatment in Group S. Their compliance rates were 84.62% and 98.08%. Adverse reactions incidence in Group S was lower. Taking a 2-year follow-up period as an example, significant statistical differences existed in OS and progression-free survival rates between adenocarcinoma and squamous carcinoma. SDS and SAS had high consistency in scoring with QLQ-30 and SF-36 scales. Targeted treatment for non-small cell carcinoma patients significantly improves their life quality and reduces the incidence of adverse reactions after continuous nursing intervention.

show abstract

Section: Discussionmentioning

confidence: 99%

Life quality improvement of patients with non-small cell lung cancer undergoing targeted therapy: A case study of continuous care

Min,

Zhu,

et al. 2023

Medicine

View full text Add to dashboard Cite

show abstract

“…The hospitals and clinics across the country have raised to the occasion with careful planning and adjustments to minimize the risk of exposure while continuing with diagnosis and treatment of cancer patients with limited resources. [1][2][3] Cancer Patient Management during COVID-19 Pandemic Busheri et al…”

Section: Introductionmentioning

confidence: 99%

Cancer Patient Management during COVID-19 Pandemic: An Audit of a Single-Surgeon Unit in a COVID-Hotspot

Busheri

Nare

Banale

et al. 2021

South Asian J Cancer

View full text Add to dashboard Cite

The report evaluates the effect of coronavirus disease (COVID-19) pandemic on breast cancer treatment and management at a single-surgeon cancer care unit in one of the hotspots of COVID-19 in India. In response to the pandemic, the adjustments were made in the clinical practice to accommodate social distancing. Patient consultations were done over phone call or in-clinic visit with prior appointment to reduce the risk of exposure to COVID-19. Total number of patients that were treated at the clinic and the essential surgeries performed during the pandemic phases are summarized in the report. The methodology adopted here for care and management of the cancer patients can serve as a guiding principle for cancer care units in the country.

show abstract

Continuing cancer treatment in a “COVID HOTSPOT” in India: Are we overestimating the risks?

Cited by 2 publications

References 9 publications

Life quality improvement of patients with non-small cell lung cancer undergoing targeted therapy: A case study of continuous care

Life quality improvement of patients with non-small cell lung cancer undergoing targeted therapy: A case study of continuous care

Cancer Patient Management during COVID-19 Pandemic: An Audit of a Single-Surgeon Unit in a COVID-Hotspot

Contact Info

Product

Resources

About